Literature DB >> 30945334

Recurrent de novo MAPK8IP3 variants cause neurological phenotypes.

Shinya Iwasawa1, Kumiko Yanagi2, Atsuo Kikuchi1, Yasuko Kobayashi3,4, Kazuhiro Haginoya4,5, Hiroshi Matsumoto6, Kenji Kurosawa7, Masayuki Ochiai8, Yasunari Sakai8, Atsushi Fujita9, Noriko Miyake9, Tetsuya Niihori10, Matsuyuki Shirota11, Ryo Funayama12, Shigeaki Nonoyama6, Shouichi Ohga8, Hiroshi Kawame13, Keiko Nakayama12, Yoko Aoki10, Naomichi Matsumoto9, Tadashi Kaname2, Yoichi Matsubara2, Wataru Shoji14, Shigeo Kure1,13.   

Abstract

c-Jun-amino-terminal kinase-interacting protein 3 (JIP3), encoded by MAPK8IP3, is an adaptor protein of the kinesin-1 complex and essential for axonal transport in neurons. However, an association between MAPK8IP3 variants and human disease has not been established. We identified 5 individuals from four families with recurrent de novo variants c.1732C>T (p.Arg578Cys) and c.3436C>T (p.Arg1146Cys) in MAPK8IP3. The core phenotype includes spastic diplegia, intellectual disability, cerebral atrophy, and corpus callosum hypoplasia. Zebrafish embryos overexpressing human mutant JIP3 showed axon varicosities of the posterior lateral line nerve, suggesting an adverse effect on the developing axons. Our results suggest that MAPK8IP3 variants cause a neurodevelopmental disease. ANN NEUROL 2019;85:927-933.
© 2019 American Neurological Association.

Entities:  

Year:  2019        PMID: 30945334     DOI: 10.1002/ana.25481

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  JIP3 interacts with dynein and kinesin-1 to regulate bidirectional organelle transport.

Authors:  Ricardo Celestino; José B Gama; Artur F Castro-Rodrigues; Daniel J Barbosa; Helder Rocha; Ennio A d'Amico; Andrea Musacchio; Ana Xavier Carvalho; João H Morais-Cabral; Reto Gassmann
Journal:  J Cell Biol       Date:  2022-07-13       Impact factor: 8.077

2.  Loss of MAPK8IP3 Affects Endocytosis in Neurons.

Authors:  Amanda M Snead; Swetha Gowrishankar
Journal:  Front Cell Neurosci       Date:  2022-05-27       Impact factor: 6.147

Review 3.  Lysosome Function and Dysfunction in Hereditary Spastic Paraplegias.

Authors:  Daisy Edmison; Luyu Wang; Swetha Gowrishankar
Journal:  Brain Sci       Date:  2021-01-24

4.  MAP3K6 Mutations in a Neurovascular Disease Causing Stroke, Cognitive Impairment, and Tremor.

Authors:  Andreea Ilinca; Elisabet Englund; Sofie Samuelsson; Katarina Truvé; Efthymia Kafantari; Nicolas Martinez-Majander; Jukka Putaala; Claes Håkansson; Arne G Lindgren; Andreas Puschmann
Journal:  Neurol Genet       Date:  2021-01-21

5.  JIP3 links lysosome transport to regulation of multiple components of the axonal cytoskeleton.

Authors:  N M Rafiq; L L Lyons; S Gowrishankar; P De Camilli; S M Ferguson
Journal:  Commun Biol       Date:  2022-01-10

6.  Mapping the sequence specificity of heterotypic amyloid interactions enables the identification of aggregation modifiers.

Authors:  Nikolaos Louros; Meine Ramakers; Emiel Michiels; Katerina Konstantoulea; Chiara Morelli; Teresa Garcia; Nele Moonen; Sam D'Haeyer; Vera Goossens; Dietmar Rudolf Thal; Dominique Audenaert; Frederic Rousseau; Joost Schymkowitz
Journal:  Nat Commun       Date:  2022-03-15       Impact factor: 17.694

7.  Six years' accomplishment of the Initiative on Rare and Undiagnosed Diseases: nationwide project in Japan to discover causes, mechanisms, and cures.

Authors:  Yuji Takahashi; Hidetoshi Date; Hideki Oi; Takeya Adachi; Noriaki Imanishi; En Kimura; Hotake Takizawa; Shinji Kosugi; Naomichi Matsumoto; Kenjiro Kosaki; Yoichi Matsubara; Hidehiro Mizusawa
Journal:  J Hum Genet       Date:  2022-03-23       Impact factor: 3.755

8.  Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy.

Authors:  Kai Guo; Stephanie A Eid; Sarah E Elzinga; Crystal Pacut; Eva L Feldman; Junguk Hur
Journal:  Clin Epigenetics       Date:  2020-08-12       Impact factor: 6.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.